|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 12, 2021 11:12AM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
Aug 12, 2020 03:46PM
|
|
New Video -@ the BIO
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 08:45AM
|
|
Re: Filled!
|
2
|
Zenith Epigenetics
|
Jan 21, 2021 04:49PM
|
|
Re: Is this bad for RVX but right, on the money?
|
2
|
Resverlogix Corp.
|
Apr 19, 2020 08:35AM
|
|
Re: Questions about units
|
2
|
Resverlogix Corp.
|
May 18, 2019 08:17PM
|
|
Secondary Outcome Measures
|
2
|
Resverlogix Corp.
|
Oct 11, 2019 12:14PM
|
|
BusinessWire-Japanes... Patent-
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 15, 2019 09:25AM
|
|
Re: Deadlines missed? Results Late? Not really.
|
2
|
Resverlogix Corp.
|
Jan 12, 2019 11:13AM
|
|
Re: ZHCLF
|
2
|
Zenith Epigenetics
|
Jan 03, 2024 06:48PM
|
|
Re: Shares and Warrants to be listed on TSX June 7th
|
2
|
Resverlogix Corp.
|
Jun 06, 2019 04:56PM
|
|
Re: Don Bio at Wallmine
|
2
|
Resverlogix Corp.
|
Oct 07, 2020 01:12PM
|
|
Re: Golden Age for Biotech's - I know one not that golden
|
2
|
Resverlogix Corp.
|
Dec 13, 2020 11:47AM
|
|
Re: Soliciting a loan to shorters
|
2
|
Resverlogix Corp.
|
Jul 26, 2019 12:46PM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 18, 2023 08:18AM
|
|
Re: Hepalink IPO Document and what it says about RVX
|
2
|
Resverlogix Corp.
|
Jan 27, 2020 08:03AM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
2
|
Zenith Epigenetics
|
Sep 03, 2018 06:06AM
|
|
Re: An email and response from another poster.
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 05:43PM
|
|
Re: New Apabetalone Fabry Disease Publication
|
2
|
Resverlogix Corp.
|
Apr 29, 2022 02:45PM
|
|
Re: Saudi
|
2
|
Resverlogix Corp.
|
Jan 13, 2021 10:17AM
|
